| Hallmarks of ribosomopathies KR Kampen, SO Sulima, S Vereecke, K De Keersmaecker Nucleic acids research 48 (3), 1013-1028, 2020 | 190 | 2020 |
| Ribosomal frameshifting in the CCR5 mRNA is regulated by miRNAs and the NMD pathway AT Belew, A Meskauskas, S Musalgaonkar, VM Advani, SO Sulima, ... Nature 512 (7514), 265-269, 2014 | 187 | 2014 |
| How ribosomes translate cancer SO Sulima, IJF Hofman, K De Keersmaecker, JD Dinman Cancer discovery 7 (10), 1069-1087, 2017 | 183 | 2017 |
| Ribosomopathies and the paradox of cellular hypo-to hyperproliferation K De Keersmaecker, SO Sulima, JD Dinman Blood, The Journal of the American Society of Hematology 125 (9), 1377-1382, 2015 | 120 | 2015 |
| Bypass of the pre-60S ribosomal quality control as a pathway to oncogenesis SO Sulima, S Patchett, VM Advani, K De Keersmaecker, AW Johnson, ... Proceedings of the National Academy of Sciences 111 (15), 5640-5645, 2014 | 92 | 2014 |
| The T-cell leukemia-associated ribosomal RPL10 R98S mutation enhances JAK-STAT signaling T Girardi, S Vereecke, SO Sulima, Y Khan, L Fancello, JW Briggs, ... Leukemia 32 (3), 809-819, 2018 | 87 | 2018 |
| Cancer biogenesis in ribosomopathies SO Sulima, KR Kampen, K De Keersmaecker Cells 8 (3), 229, 2019 | 85 | 2019 |
| Eukaryotic rpL10 drives ribosomal rotation SO Sulima, SP Gülay, M Anjos, S Patchett, A Meskauskas, AW Johnson, ... Nucleic Acids Research 42 (3), 2049-2063, 2014 | 81 | 2014 |
| The ribosomal RPL10 R98S mutation drives IRES-dependent BCL-2 translation in T-ALL KR Kampen, SO Sulima, B Verbelen, T Girardi, S Vereecke, G Rinaldi, ... Leukemia 33 (2), 319-332, 2019 | 77 | 2019 |
| Translatome analysis reveals altered serine and glycine metabolism in T-cell acute lymphoblastic leukemia cells KR Kampen, L Fancello, T Girardi, G Rinaldi, M Planque, SO Sulima, ... Nature communications 10 (1), 2542, 2019 | 65 | 2019 |
| Ribosomal lesions promote oncogenic mutagenesis SO Sulima, KR Kampen, S Vereecke, D Pepe, L Fancello, J Verbeeck, ... Cancer research 79 (2), 320-327, 2019 | 36 | 2019 |
| The expanding riboverse SO Sulima, JD Dinman Cells 8 (10), 1205, 2019 | 19 | 2019 |
| Rise of the specialized onco-ribosomes KR Kampen, SO Sulima, K De Keersmaecker Oncotarget 9 (81), 35205, 2018 | 15 | 2018 |
| Ribosomal proteins: A novel class of oncogenic drivers SO Sulima, K De Keersmaecker Oncotarget 8 (52), 89427, 2017 | 12 | 2017 |
| Bloody mysteries of ribosomes SO Sulima, K De Keersmaecker Hemasphere 2 (5), e95, 2018 | 8 | 2018 |
| Exploitation of the ribosomal protein L10 R98S mutation to enhance recombinant protein production in mammalian cells B Verbelen, T Girardi, SO Sulima, S Vereecke, P Verstraete, J Verbeeck, ... Engineering in Life Sciences 22 (2), 100-114, 2022 | | 2022 |
| Correction: The ribosomal RPL10 R98S mutation drives IRES-dependent BCL-2 translation in T-ALL (Leukemia,(2019), 33, 2,(319-332), 10.1038/s41375-018-0176-z) KR Kampen, SO Sulima, B Verbelen, T Girardi, S Vereecke, L Fancello, ... Leukemia 33 (4), 1055-1062, 2019 | | 2019 |
Kim De KeersmaeckerKU LeuvenE-mail megerősítve itt: kuleuven.be
